Cargando…

Blocking the CCL5–CCR5 Axis Using Maraviroc Promotes M1 Polarization of Macrophages Cocultured with Irradiated Hepatoma Cells

PURPOSE: The C-C chemokine ligand 5 (CCL5)–C-C chemokine receptor (CCR5) axis facilitates tumor progression via multiple mechanisms. Herein, we elucidated the effect of a CCR5 antagonist (maraviroc [MVC]; blocking the CCL5–CCR5 axis) on the phenotype of macrophages cocultured with irradiated hepatom...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhuang, Yuan, Zhao, Xiaomei, Yuan, Baoying, Zeng, Zhaochong, Chen, Yixing
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8219307/ https://www.ncbi.nlm.nih.gov/pubmed/34178876 http://dx.doi.org/10.2147/JHC.S300165

Ejemplares similares

The CCL5/CCR5 Axis in Cancer Progression
por: Aldinucci, Donatella, et al.
Publicado: (2020)

Cytokine CCL5 and Receptor CCR5 Axis in Glioblastoma Multiforme
por: Kranjc, Miha Koprivnikar, et al.
Publicado: (2019)

CCL5/CCR5 axis in human diseases and related treatments
por: Zeng, Zhen, et al.
Publicado: (2021)

The intricate role of CCL5/CCR5 axis in Alzheimer disease
por: Ma, Weijiang, et al.
Publicado: (2023)

Maraviroc – A CCR5 Antagonist for the Treatment of HIV-1 Infection
por: Van Der Ryst, Elna
Publicado: (2015)

Relevance of CCL3/CCR5 axis in oral carcinogenesis
por: da Silva, Janine Mayra, et al.
Publicado: (2017)

The CCL5/CCR5 axis promotes metastasis in basal breast cancer
por: Velasco-Velázquez, Marco, et al.
Publicado: (2013)

Inhibition of the CCL5/CCR5 Axis against the Progression of Gastric Cancer
por: Aldinucci, Donatella, et al.
Publicado: (2018)

Biological and Clinical Significance of the CCR5/CCL5 Axis in Hepatocellular Carcinoma
por: Singh, Santosh K., et al.
Publicado: (2020)

New approaches in the treatment of HIV/AIDS – focus on maraviroc and other CCR5 antagonists
por: Schlecht, Hans P, et al.
Publicado: (2008)

Profile of maraviroc: a CCR5 antagonist in the management of treatment-experienced HIV patients
por: Lorenzen, Thore
Publicado: (2010)

CCR5 antagonism by maraviroc inhibits Hodgkin lymphoma microenvironment interactions and xenograft growth
por: Casagrande, Naike, et al.
Publicado: (2019)

Triptolide Attenuates Neuropathic Pain by Regulating Microglia Polarization through the CCL2/CCR2 Axis
por: Bao, Xubin, et al.
Publicado: (2021)

CCR5/CCL5 axis interaction promotes migratory and invasiveness of pancreatic cancer cells
por: Singh, Santosh Kumar, et al.
Publicado: (2018)

Maraviroc, a CCR5 Antagonist, Prevents Development of Hepatocellular Carcinoma in a Mouse Model
por: Ochoa-Callejero, Laura, et al.
Publicado: (2013)

Role of periostin in inflammatory bowel disease development and synergistic effects mediated by the CCL5–CCR5 axis
por: Mukanova, Saida, et al.
Publicado: (2022)

Epigenetic Modification of the CCL5/CCR1/ERK Axis Enhances Glioma Targeting in Dedifferentiation-Reprogrammed BMSCs
por: Chen, Rui, et al.
Publicado: (2017)

Stochastic Model of In-Vivo X4 Emergence during HIV Infection: Implications for the CCR5 Inhibitor Maraviroc
por: Savkovic, Borislav, et al.
Publicado: (2012)

Pharmacokinetics, Safety and Efficacy of Maraviroc in Treatment-experienced Pediatric Patients Infected With CCR5-Tropic HIV-1
por: Giaquinto, Carlo, et al.
Publicado: (2018)

A randomized controlled clinical trial on the impact of CCR5 blockade with maraviroc in early infection on T-cell dynamics
por: Karris, Maile Y., et al.
Publicado: (2016)

The CCR5 antagonist maraviroc exerts limited neuroprotection without improving neurofunctional outcome in experimental pneumococcal meningitis
por: Le, Ngoc Dung, et al.
Publicado: (2022)

The CCL20-CCR6 Axis in Cancer Progression
por: Kadomoto, Suguru, et al.
Publicado: (2020)

Chemokine Profile and the Alterations in CCR5-CCL5 Axis in Geographic Atrophy Secondary to Age-Related Macular Degeneration
por: Krogh Nielsen, Marie, et al.
Publicado: (2020)

Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
por: Qiu, Yue, et al.
Publicado: (2021)

MicroRNA-146a-5p attenuates irradiation-induced and LPS-induced hepatic stellate cell activation and hepatocyte apoptosis through inhibition of TLR4 pathway
por: Chen, Yuhan, et al.
Publicado: (2018)

CCL5 and CCR5 Interaction Promotes Cell Motility in Human Osteosarcoma
por: Wang, Shih-Wei, et al.
Publicado: (2012)

The CCR5-antagonist Maraviroc reverses HIV-1 latency in vitro alone or in combination with the PKC-agonist Bryostatin-1
por: López-Huertas, María Rosa, et al.
Publicado: (2017)

A CCR5 antagonist, maraviroc, alleviates neural circuit dysfunction and behavioral disorders induced by prenatal valproate exposure
por: Ishihara, Yasuhiro, et al.
Publicado: (2022)

Elucidating a Key Anti-HIV-1 and Cancer-Associated Axis: The Structure of CCL5 (Rantes) in Complex with CCR5
por: Tamamis, Phanourios, et al.
Publicado: (2014)

Corrigendum: Myeloid-Derived Suppressor Cells Alleviate Renal Fibrosis Progression via Regulation of CCL5-CCR5 Axis
por: Qiu, Yue, et al.
Publicado: (2021)

HIV-1 predisposed to acquiring resistance to maraviroc (MVC) and other CCR5 antagonists in vitro has an inherent, low-level ability to utilize MVC-bound CCR5 for entry
por: Roche, Michael, et al.
Publicado: (2011)

Characterizing the Diverse Mutational Pathways Associated with R5-Tropic Maraviroc Resistance: HIV-1 That Uses the Drug-Bound CCR5 Coreceptor
por: Jiang, Xiaowei, et al.
Publicado: (2015)

Roles of CCL2-CCR2 Axis in the Tumor Microenvironment
por: Kadomoto, Suguru, et al.
Publicado: (2021)

Targeting the CCL2-CCR2 axis in depressive disorders
por: Curzytek, Katarzyna, et al.
Publicado: (2021)

Hippocampal CCR5/RANTES Elevations in a Rodent Model of Post-Traumatic Stress Disorder: Maraviroc (a CCR5 Antagonist) Increases Corticosterone Levels and Enhances Fear Memory Consolidation
por: Merino, José Joaquín, et al.
Publicado: (2020)

CCR5 Antagonist Maraviroc Inhibits Acute Exacerbation of Lung Inflammation Triggered by Influenza Virus in Cigarette Smoke-Exposed Mice
por: Ferrero, Maximiliano Ruben, et al.
Publicado: (2021)

Prevention of CaCl(2)-induced aortic inflammation and subsequent aneurysm formation by the CCL3–CCR5 axis
por: Ishida, Yuko, et al.
Publicado: (2020)

Targeting the CCL2-CCR2 signaling axis in cancer metastasis
por: Lim, Su Yin, et al.
Publicado: (2016)

The Role of CCL20-CCR6 Axis in Ovarian Cancer Metastasis
por: Liu, Wan, et al.
Publicado: (2020)

CCL17‐CCR4 axis contributes to the onset of vitiligo in mice
por: Li, He, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t9s1kq3o5pmbt487g5rkg9b3eq